Skip to main content
Emad Dean Nukta, MD, Cardiology, Cleveland, OH, Cleveland Clinic Fairview Hospital

Emad DeanNuktaMDFACP, FACC, FSCAI, FSVM

Cardiology Cleveland, OH

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine

Interventional Cardiologist at Cleveland Clinic, Ohio

Dr. Nukta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nukta's full profile

Already have an account?

Education & Training

  • University Of Geneva
    University Of GenevaFellowship, Interventional Cardiology with Dr. Bernhard Meier, 1989 - 1990
  • Wright State University
    Wright State UniversityFellowship, Cardiovascular Disease, 1986 - 1988
  • Cleveland Clinic Foundation/Fairview Hospital
    Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 1983 - 1986
  • Damascus University Faculty of Medicine
    Damascus University Faculty of MedicineClass of 1981

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1985 - 2026
  • GA State Medical License
    GA State Medical License 1984 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Interventional Cardiology
  • Society of Vascular Medicine Board Certified in Endovascular Medicine

Awards, Honors, & Recognition

  • Physician of the year Cleveland clinic/Fairview, 2023
  • Fellow American College of Physicians
  • Fellow The Society of Cardiac Angiography and Interventions, 1995, 2015
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • The Mynx(R) Vascular Closure Device; adopting extravascular closure technology in the catherization lab  
    Nukta ED, Endovascular Today, 1/1/2009
  • Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention (...  
    Nukta ED, Journal of the American Medical Association, 1/19/2003
  • First Use of a Novel Cobalt Chromium Coronary Stent Alloy in Man: Procedural and Late Outcomes (VISION Trial)  
    Nukta ED, Journal of American College of Cardiology, 1/19/2003
  • Join now to see all

Abstracts/Posters

  • Late Outcomes of Patients Treated With the ev3 X-SIZER Thromboatherectomy Device – Results From the X-TRACT Trial
    Nukta ED, ACC, 1/1/2004
  • Utility of Thrombectomy in Women Undergoing Stenting of Diseased Saphenous Vein Grafts and Thrombus Containing Native Coronary Arteries-Results From the X-TRACT Trial
    Nukta ED, TCT, 1/1/2003
  • Impact of Gender on Outcomes of Thrombectomy in Patients Undergoing Stenting of Diseased Saphenous Vein Grafts or Thrombotic Native Coronary Arteries-Results From the ...
    Nukta ED, TCT, 1/1/2003
  • Join now to see all

Research History

  • Co auther1980 - 2023

Professional Memberships

Hospital Affiliations